Multimin North America

Multimin North America is a U.S.-based animal health company focused on injectable trace mineral supplementation for cattle. Its lead and apparently primary commercial product is MULTIMIN 90, an FDA-approved prescription animal drug that provides zinc, copper, manganese, and selenium by subcutaneous injection. The product is marketed for beef and dairy cattle as a strategic supplement to support mineral status during key production and stress periods. The company operates in veterinary pharmaceuticals and animal nutrition rather than human biopharma, with commercial activity centered in the United States and broader international brand presence through the Multimin franchise. Public materials also indicate a relationship with Axiota Animal Health, whose site now hosts current MULTIMIN product information and the April 2024 FDA approval announcement.